PPARgamma agonists as new therapeutic agents for the treatment of Alzheimer's disease.
Landreth
Gary
G
Department of Neurosciences, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA. gel2@case.edu
D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D047495:PPAR gamma / Q000819:agonists* / Q000502:physiology; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
D047495:PPAR gamma; D045162:Thiazolidinediones; D000077154:Rosiglitazone